← Leaderboards
Piotr W Rzepecki
Echelon Biosciences, Inc.
$693,059
Attributed
$693,059
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $449.4K · FY2008–14$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
FDA$599,310 · 2
NIH$93,749 · 1
By mechanism
R44$449,426 · 1
R43$243,633 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Agonist”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Alan G. Barbour · University Of California Irvine$40,092,035
- Alexandros Makriyannis · University Of Connecticut Storrs$29,942,402
- Scott T Weiss · University Of California, San Diego$28,624,344
- John Didsbury · T3d Therapeutics, Inc.$25,150,614
Research focus
AgonistAnalogApoptosisApoptoticBaseBinding (Molecular Function)Binding SitesBiologicalCalciumCalcium BindingCalcium SignalingCellsCell SurvivalCerebrovascularChargeComputer SimulationCytochrome CDeprivationDesignDeveloped CountriesDockingDyesElderlyAffect